Skip to main content
Download PDF

Causality of the gut microbiome and atherosclerosis-related lipids: a bidirectional Mendelian Randomization study

BMC Cardiovascular Disorders volume 24, Article number: 138 (2024) Cite this article

Abstract

Aims

Recent studies have indicated an association between intestinal flora and lipids. However, observational studies cannot indicate causality. In this study, we aimed to investigate the potentially causal relationships between the intestinal flora and blood lipids.

Methods

We performed a bidirectional two-sample Mendelian Randomization (MR) analysis to investigate the causal relationship between intestinal flora and blood lipids. Summary statistics of genome-wide association studies (GWASs) for the 211 intestinal flora and blood lipid traits (n = 5) were obtained from public datasets. Five recognized MR methods were applied to assess the causal relationship with lipids, among which, the inverse-variance weighted (IVW) regression was used as the primary MR method. A series of sensitivity analyses were performed to test the robustness of the causal estimates.

Results

The results indicated a potential causal association between 19 intestinal flora and dyslipidemia in humans. Genus Ruminococcaceae, Christensenellaceae, Parasutterella, Terrisporobacter, Parabacteroides, Class Erysipelotrichia, Family Erysipelotrichaceae, and order Erysipelotrichales were associated with higher dyslipidemia, whereas genus Oscillospira, Peptococcus, Ruminococcaceae UCG010, Ruminococcaceae UCG011, Dorea, and Family Desulfovibrionaceae were associated with lower dyslipidemia. After using the Bonferroni method for multiple testing correction, Only Desulfovibrionaceae [Estimate = -0.0418, 95% confidence interval [CI]: 0.9362–0.9826, P = 0.0007] exhibited stable and significant negative associations with ApoB levels. The inverse MR analysis did not find a significant causal effect of lipids on the intestinal flora. Additionally, no significant heterogeneity or horizontal pleiotropy for IVs was observed in the analysis.

Conclusion

The study suggested a causal relationship between intestinal flora and dyslipidemia. These findings will provide a meaningful reference to discover dyslipidemia for intervention to address the problems in the clinic.

Peer Review reports

Introduction

At present, cardiovascular disease (CVD) remains the primary contributor to the marked upswing in global mortality [1]. According to the latest statistical data from NHANES, the current overall prevalence of CVD is 49.2%, with the number of affected individuals reaching staggering 126.9 million [2]. Dyslipidemia is an important driver of CVD progression. Elevated plasma concentrations of LDL cholesterol (LDL-C) and triglycerides (TG) and low concentration of HDL cholesterol (HDL-C) are leading contributors to an increased risk for CVD [3,4,5]. What's more crucial is that lipoproteins, as particles with complex compositions, include apolipoproteins as indispensable and vital components [6]. Apolipoproteins can be widely involved in a variety of pathophysiological processes such as atherosclerosis formation [7,8,9,10]. Therefore, lowering plasma lipoprotein levels will undoubtedly reduce the incidence of CVD [11]. At this stage, although statin therapy has achieved remarkable and brilliant success [12], researchers are still searching for new therapeutic approaches to combat CVD, in which the close relationship between intestinal flora and lipid levels has attracted increasing attention.

The intestinal flora consists of approximately 4 × 1013 commensal bacteria, also known as the “human second genome” [13]. Interventions on intestinal flora have become an important breakthrough in improving health [14, 15]. Fecal transplantation in rodents suggests that the intestinal flora holds promise for treating chronic diseases [16, 17]. Likewise, the important role of intestinal flora in CVD is becoming apparent. Takuo’s study demonstrates a correlation between coronary heart disease incidences and intestinal flora changes [18]. Xuzhi Wan et al.find that changing the abundance of certain intestinal flora affects blood lipid levels to some extent [19]. Prevotella and Bacteroides in men and Akkermansia and Escherichia/Shigella in women may be associated with blood lipid levels in an observational study in Japan [20]. However, most of these studies are observational, and the results may be confounded by reverse causality or confounding factors such as diet and antibiotics, making the conclusions less reliable.

Mendelian Randomization (MR) analysis is an important method to explore the causal relationship between exposure and outcome by using genetic variants as instrumental variables (IVs) [21]. Its obvious advantage is that it can avoid the interference of confounding factors in traditional observational studies [22, 23]. This is particularly fundamental in inferring causality. MR analysis can more reliably infer the causal relationship between intestinal flora and blood lipids. On this basis, we performed a two-sample MR analysis to investigate the causal relationship between intestinal flora and blood lipids. This may provide new treatments such as probiotic therapy, dietary modification, and fecal microbiota transplantation (FMT) for CVD in the future.

Materials and Methods

Study design

As shown in Fig. 1, this study was based on a two-sample MR approach to explore the causal relationship between intestinal flora and blood lipids. Compared with single-sample MR, two-sample MR did not need to obtain individual genetic data but used summary statistical information from genome-wide association studies (GWAS) for analysis.

Fig. 1
figure 1

Design of the study. We obtained raw data on intestinal flora and lipids from the GWAS database. The statistically significant intestinal flora was then screened according to P IVW< 0.05 and P WM< 0.05 and subjected to detailed analysis and reverse MR studies. F F-statistics. r2 the genetic variants for instrument, IVs instrumental variables

Full size image

Data sources

Summary statistics for intestinal flora taxa were obtained from a large-scale multi-ethnic GWAS meta-analysis from 24 cohorts with 18,340 individuals [24]. A total of 211 taxa (131 genera, 35 families, 20 orders, 16 classes, and 9 phyla) were included. For the outcomes – serum lipids—summary statistics were obtained from a GWAS study that included up to 441,016 participants from UKBB [25], available from IEU Open GWAS Database (IEU OpenGWAS project (mercies. ac. UK)).

The GWAS summary data for intestinal flora and serum lipids are obtained from a database of samples collected from European populations, with minimal potential for sample overlap. The source of the data was also approved by the appropriate ethics committee, and therefore no ethical approval was required for this study [25].

Instrumental variables selection

We performed rigorous quality control (QC) on the single-nucleotide polymorphisms (SNPs) in the microbiota-based GWAS summary studies to select valid IVs for MR analysis. Firstly, the IVs chosen must have a strong association with the exposure, we selected SNPs associated with each genus at the locus-wide significance threshold (P < 1.0 × 10–5) as potential IVs [26]. Secondly, we clustered SNPs according to the European 1000 Genomes Project reference panel (r2 < 0.01, clump distance > 10,000 kb) to identify independent SNPs [27]] Thirdly, we excluded palindromes and incompatible SNPs when harmonizing exposure and outcome statistics. Fourthly, to avoid the effect of weak instrumental bias on causal inference, we also calculated the F-statistic [28]. SNPs with F-values less than 10 were excluded [29].

MR analysis

We used MR analysis to analyze the causal relationship between intestinal flora and serum lipids. Five prevalent MR methods were employed to estimate the associations between 211 selected intestinal microbiota IVs and each outcome: inverse-variance weighted (IVW) test [30], MR-Egger regression [31], weighted median (WM) [31], Simple mode, and weighted mode [32]. Of these, we used IVW as the primary method of analysis because, without horizontal pleiotropy, the IVW method of analysis would be unbiased [33]. In addition, WM is an important complementary method, which assumes that less than 50% of IVs have horizontal pleiotropy [34].This makes the reliability of the results more robust. If the MR analysis results were nominally significant (P < 0.05), we considered that there might be a causal relationship between the intestinal flora and the lipids. The results were considered robust when two or even more MR analysis methods including IVW and WM were significant [35].

We conducted a further sensitivity analysis to make our results more reliable. Conchrane's Q test was used to detect heterogeneity among IVs. Leave-one-out sensitivity analysis was also used to detect potentially influential IVs [36]. Furthermore, to ascertain that the outcomes are influenced by genetic variation rather than other biological pathways, excluding the impact of horizontal pleiotropy, we employed a variety of methods to detect possible horizontal pleiotropy. MR- egger intercept test and global test for outliers (MR-PRESSO) were used to assess the presence of horizontal pleiotropy and results were considered unaffected by horizontal pleiotropy if P > 0.05 [37, 38]. The MR-PRESSO outlier test can be used to moderate horizontal pleiotropy by detecting and removing outliers [38].

To obtain a more rigorous interpretation of causality, we performed a Bonferroni correction based on the number of bacteria under each attribute [genera: 0.05/131 (3.8 × 10−4), families: 0.05/35 (1.4 × 10−3), orders: 0.05/20 (2.5 × 10−3), classes: 0.05/16 (3.1 × 10−3), and phyla: 0.05/9 (5.5 × 10−3)]. Finally, we also performed reverse MR analysis. We treat the significant intestinal flora in two-sample MR studies as the outcome and lipids as the exposure to verify the existence of reverse causality. All statistical analyses were conducted using R (Version 4.1.2) with the two-sample MR [39] and MR-PRESSO packages [38].

Results

Instrumental variable selection and initial MR analysis results

The results obtained after the initial analysis of 211 intestinal flora are shown in Supplementary Table S1. We used five MR methods to analyze the causal relationship between intestinal flora and the different lipids in the serum. Using the IVW approach (P < 0.05), we initially screened 65 intestinal flora for a potential causal relationship with blood lipids (Supplementary Table S2). Subsequently, among the significant findings, we conducted a double verification using the IVW method integrated with the WM method and observed that only 19 intestinal flora exhibited more robust results in the analysis. (Supplementary Table S3-4). Our study primarily centered on these 19 specific intestinal flora. All SNPs F values exceed 10 (Supplementary Table S5); hence, the existence of a weak instrumental bias is not considered.

Detailed Two-Sample MR results

ApoA

Sixteen intestinal flora were identified as causally related to ApoA through screening with the IVW method (Supplementary Table S2). However, upon integration with the WM method, we inferred that only the genus Ruminococcaceae exhibited a suggestive causal relationship with higher ApoA [Estimate = 0.0513, 95% confidence interval [CI]: 1.0238–1.0823, P = 0.0003] (Table 1). MR-Egger intercept test and MR-PRESSO global test suggested that there was no horizontal pleiotropy or outliers (P > 0.05) (Table 3).

Table 1. MR results of causal relationships between intestinal flora and both Apo A, and ApoB (PIVW < 0.05 and PWM < 0.05). Nsnp Number of the SNP used as the IVs for the MR analyses, IVW inverse variance weighted, WM Weighted median, CI Confidence interval
Full size table

ApoB

We used the IVW method to screen twenty intestinal flora that were causally related to ApoB (P < 0.05) (Supplementary Table S2). To make the results more reliable, we obtained 9 stable results when considering WM analysis. As shown in Table 1, We found that the genus Christensenellaceae [Estimate = 0.0471, 95% confidence interval [CI]: 1.0038–1.0947, P = 0.0329], genus Parasutterella [Estimate = 0.0316, 95% confidence interval [CI]: 1.0133–1.0512, P= 0.0008], and genus Terrisporobacter [Estimate = 0.0358, 95% confidence interval [CI]: 1.0145–1.0589,  P= 0.0010] were positively correlated with the serum level of ApoB. Differently, family Desulfovibrionaceae [Estimate = -0.0418, 95% confidence interval [CI]: 0.9362–0.9826,  P= 0.0007], genus Oscillospira [Estimate = -0.0267, 95% confidence interval [CI]: 0.9531–0.9947, P = 0.0145], genus Peptococcus [Estimate = -0.0195, 95% confidence interval [CI]: 0.9679–0.9937, P = 0.0037], genus Ruminococcaceae UCG010 [Estimate = -0.0421, 95% confidence interval [CI]: 0.9201–0.9990,  P= 0.0447], genus Ruminococcaceae UCG011 [Estimate = -0.0148, 95% confidence interval [CI]: 0.9726–0.9982,  P= 0.0259], and order Desulfovibrionales [Estimate = -0.0323, 95% confidence interval [CI]: 0.9443–0.9928, P= 0.0115] showed a negative association with serum levels of ApoB. The scatter plots and forest plots for the analyses are shown in Supplementary Figs. 5–6.

Next, to further demonstrate the reliability of our results, we carried out a sensitivity analysis. As shown in Table 3, except for the genus Christensenellaceae group, no heterogeneity was found in the other groups (Cochrane’s Q test, P > 0.05). MR-Egger intercept test and MR-PRESSO global test suggest that there was no horizontal pleiotropy or outliers in all groups (P > 0.05).

LDL-C

By employing the IVW method, we identified causal associations between eleven intestinal flora and LDL-C (Supplementary Table S2). After integrated with WM method, three bacterial taxa were still stable. Our MR analysis found that the genus Oscillospira [Estimate = -0.0257, 95% confidence interval [CI]: 0.9519–0.9519, P = 0.0322] was considerably associated with lower LDL-C. While the genus Parasutterella [Estimate = 0.0254, 95% confidence interval [CI]: 1.0090–1.0427, P = 0.0025] and genus Terrisporobacter [Estimate = 0.0364, 95% confidence interval [CI]: 1.0110–1.6038, P = 0.0050] were considerably associated with higher LDL-C (Table 2). The scatter plots and forest plots for the analyses are shown in Supplementary Figs. 9–10. Based on the results of the MR-Egger and MR-PRESSO tests, no horizontal pleiotropy or outliers were found (P > 0.05) (Table 3). No significant heterogeneity was found in the results of Cochrane's Q test (P > 0.05).

Table 2. MR results of causal relationships between intestinal flora and LDL-C, HDL-C, and TG (PIVW < 0.05 and PWM < 0.05). Nsnp Number of the SNP used as the IVs for the MR analyses, IVW Inverse variance weighted, WM Weighted median, CI Confidence interval
Full size table
Table 3. Results of heterogeneity and horizontal pleiotropy
Full size table

HDL-C

The IVW method revealed a causal relationship between twenty-one intestinal flora and HDL-C (Supplementary Table S2). However, after considering WM method, only five bacterial taxa remained stable. In specific, class Erysipelotrichia [Estimate = 0.0219, 95% confidence interval [CI]: 1.0090–1.0427, P = 0.0401], family Erysipelotrichaceae [Estimate = 0.0219, 95% confidence interval [CI]: 1.0090–1.0427, P = 0.0401], genus Parabacteroides [Estimate = 0.0418, 95% confidence interval [CI]: 1.0090–1.0427, P = 0.0026], genus Ruminococcaceae[Estimate = 0.0514, 95% confidence interval [CI]: 1.0090–1.0427, P = 0.0114], and order Erysipelotrichales [Estimate = 0.0219, 95% confidence interval [CI]: 1.0090–1.0427, P = 0.0401] were considerably associated with higher HDL-C (Table 2). The scatter plots and forest plots for the analyses are shown in Supplementary Figs. 13–14. The results of the MR-Egger and MR-PRESSO tests confirmed that there was no horizontal pleiotropy (P > 0.05) and the outcomes from Cochrane’s Q test demonstrated that there was no obvious heterogeneity among the selected SNPs (P > 0.05).

TG

Using the IVW method, we preliminarily screened six intestinal flora associated with TG (Supplementary Table S2). Only one bacterial taxon remained stable after WM method validation. Specifically speaking, a higher genetically predicted genus Dorea [Estimate = -0.0256, 95% confidence interval [CI]: 0.9513–0.9986, P = 0.0384] was associated with a lower level of TG (Table 2). No significant heterogeneity or horizontal pleiotropy was found based on the results of Cochrane's Q, MR-Egger, and MR-PRESSO tests (P > 0.05) (Table 3).

Bonferroni-corrected test and sensitivity analysis

After the Bonferroni-correction test, only Desulfovibrionaceae falls below the Bonferroni-corrected threshold (Supplementary Table S6). This indicates that higher levels of Desulfovibrionaceae [Estimate = -0.0418, 95% confidence interval [CI]: 0.9362–0.9826, P = 0.0007] still exhibit a more significant and stable inverse causality with serum ApoB levels. Figure 2 shows significant and nominal links between intestinal flora and lipids.

Fig. 2
figure 2

Significant and nominal links between intestinal flora and lipids

Full size image

Leave-one-out analysis is a step-by-step process of removing each SNP and observing whether the results change after removing each SNP. Based on our findings, while the overall stability is observed, it appears that certain SNPs may exert a dominant influence on the positive outcomes (Supplement Figure S3,7,11,15,19). Additionally, to prevent reverse causality from interfering with the above results, we performed a reverse MR analysis with significant intestinal flora in two-sample MR studies as the outcome and lipids as the exposure on locus-wide significance level (Supplementary Table S7). There was no evidence for a causal effect of lipids on the intestinal flora.

Discussion

In the past decade, our comprehension of the intestinal flora has undergone a nearly exponential expansion [40]. The increasing recognition of the importance of the intestinal flora is helped by the advent of innovative methodologies and technologies, including germ-free animals [41], fecal microbiota transplantation [42], and omics [43]. Genetic studies have estimated that human genetics can explain 1.9%-8.1% of the variation in the gut microbiome [44, 45]. Some of these variants might be associated with certain traits, such as inflammatory bowel disease [46] and tumors [47]. Dyslipidemia is a significant risk factor for CVD. Recent investigations suggest a potential influence of the intestinal flora on circulating lipid levels. On this basis, we employed the large, publicly available GWAS database and applied MR analysis to explore the causal relationship between intestinal flora and lipids [24, 25]. In the present study, we identified a total of 19 lipid-related intestinal flora. Among them, a significant negative causal relationship exists between Desulfovibrionaceae and ApoB. Besides, no reverse causality was found by the reverse MR analysis.

Desulfovibrionaceae is an important anaerobic bacterium in the digestive tract. It has the capability to bind with human colonic mucin and is enriched on the mucosal surface of the colon [48, 49]. Researchers have noted a negative correlation between Desulfovibrio and obesity indicators such as BMI [50] and waist [51]. An important characteristic of Desulfovibrio is its ability to perform dissimilatory sulfate reduction by utilizing sulfate as an electron acceptor for respiration, thereby producing hydrogen sulfide (H2S) [52]. As an important gas transmitter, H2S is involved in numerous biological processes, including posttranslational modifications of proteins by S-sulfhydration in the cardiovascular system [53] and lipid metabolism [54]. Some studies indicate that the reduction of H2S is associated with an accelerated occurrence of atherosclerosis [55, 56]. After feeding Cystathionine γ-lyase-deficient mice to a high-fat diet for 12 weeks, Mani observed significant disturbances in lipid metabolism and early atheromatous changes in the aorta. Treatment of these animals with the rapid H2S donor sodium hydrosulfide reduced the development of atherosclerosis [55].

This may suggest that future interventions on H2S could potentially serve as a viable direction for maintaining lipid metabolism homeostasis and slowing the development of atherosclerosis. However, at the current stage, how to manipulate H2S levels in a physiologically appropriate manner is a major concern. Desulfovibrionaceae as an important endogenous source of H2S, or targeting of Desulfovibrionaceae will help future studies in this regard.

Interestingly, metagenomics revealed that Desulfovibrio can produce acetic acid [57, 58], which, as an important member of short-chain fatty acids (SCFAS), is undoubtedly essential for lipid metabolism homeostasis [59]. Acetic acid can activate the AMP-activated protein kinase signaling pathway to regulate hepatic lipid metabolism [60]. Moreover, the polymorphism of gut microbial communities, particularly those associated with lipid metabolic homeostasis, such as Coprococcus, Ruminococcus, Akkermansia, Roseburia, and Faecalibacterium, closely correlates with the relative abundance of Desulfovibrionaceae. The protective effects of Coprococcus [61], Ruminococcus [62], Akkermansia [63], Roseburia [64], and Faecalibacterium[65] are associated with the production of SCFAS. This phenomenon could have a synergistic effect with acetic acid produced by Desulfovibrionaceae, contributing to the maintenance of lipid metabolism homeostasis and the protection of host health. It is imperative to acknowledge that, while these mechanisms provide initial insights into the association between Desulfovibrionaceae and blood lipids, further investigation is still needed for a comprehensive understanding of the specific underlying mechanisms.

Additionally, ApoB functions as the primary transporter of LDL-C, and these two components are intricately connected within the organism. Elevated levels of LDL-C unquestionably expedite the progression of atherosclerosis, and our study indicates that certain intestinal flora may synergistically affect both. Oscillospira, an intestinal anaerobe, can utilize host glycans and produce butyrate [66]. Butyrate plays a crucial role in maintaining metabolic homeostasis [67]. In animal models of metabolic diseases, supplementation with butyrate reportedly confers numerous benefits, including reduced serum triglycerides, total cholesterol and glucose, and reduced weight gain in response to a high fat diet (HFD) [68,69,70] This protective effect may be attributed to epigenetic effects through inhibition of histone deacetylases (HDACs). HDACs are a group of epigenetic modifying enzymes that remove acetyl groups from histone tails, thereby modifying chromatin structure and the accessibility of genes for transcription [71]. HDACs regulate a variety of metabolic pathways and deregulation of HDACs has been associated with CVD [72]. Apart from this. Butyrate can bind and activate the G protein-coupled (GPR) free fatty acid receptors (FFAR) [73], influencing the release of gut hormones. These gut hormones may play an important role in appetite suppression and lipid metabolism [74]. In our study, Parasutterella also could affect both Apo B and LDL-C. In a study on obesity, researchers found that Parasutterella could impact human fatty acid synthesis [75]. This may exert a direct impact on ApoB production and LDL-C metabolism. Parasutterella colonies were also found to be significantly enriched in mice susceptible to obesity [76]. Future interventions targeting Parasutterella may be a feasible way to combat obesity and maintain lipid homeostasis. Apart from this, our analysis complements the findings of Lee. Lee et al. found that Terrisporobacter could affect TG and HDL-C [77], We will further delineate the causal relationship between Terrisporobacter and ApoB and LDL-C. We are confident that our study can establish a more solid research foundation for future investigations.

In addition to the "bad cholesterol" mentioned above, HDL-C is widely recognized as the "good cholesterol" in our circulation. The latest research indicates that with each unit increase in HDL-C level, there is a corresponding 2–3% reduction in the risk of CVD [78]. In the present MR analysis, we find a positive causal relationship between some intestinal flora and HDL-C, such as Erysipelotrichia. Erysipelotrichia is an important bacterium for maintaining intestinal health. Erysipelotrichia microflora transplantation has demonstrated great potential advantages in promoting intestinal regeneration after radiation [79, 80]. The crucial ability to maintain intestinal health is poised to become a significant consideration in the treatment of chronic diseases such as atherosclerosis in the future. Our results also suggest that Ruminococcaceae affects lipid metabolism. Priscilla et al. had observed a significant increase in the abundance of Ruminococcaceae in the control group compared to patients with atherosclerotic dyslipidemia [81]. According to our analysis, this increase in abundance may regulate apolipoprotein and cholesterol, consequently exerting a protective effect on the host. To our surprise, we find for the first time a potential link between Dorea and TG. Dorea [82] is a member of the family Lachnospiraceae which is reported to be strongly associated with lower TG levels in European and Chinese populations [83, 84]. Our study suggests that we cannot exclude the influence of Dorea on TG in this context, and we believe that our results can provide new evidence and confidence for the increasing of intestinal Dorea number in patients with dyslipidemia in the future.

In our study, although we did not observe a significant potential impact of blood lipids on the gut microbiota, it is important to note that certain genetic variations, such as the APOB rs693, may serve as an independent risk for dyslipidemia [85]. In this subset of patients, the importance of lipids on intestinal flora needs to be further elucidated to formulate individualized treatment plans.

We also need to acknowledge certain limitations in our study. Firstly, this study mainly included individuals of European ancestry, and additional validation is required when extending the results to other populations. Secondly, exposure factors such as diet and environment also have an impact on the composition and abundance of intestinal flora, we will treat it as the focus of our upcoming study. Lastly, despite the theoretical causal impact of certain bacterial groups, the specific mechanisms remain unclear. To elucidate the role of intestinal flora and its contribution to lipid homeostasis, both single flora transplantation and a substantial number of animal experiments are warranted. Our research team is currently engaged in related investigations to identify potential strategic targets for lipid level control.

In conclusion, our study examined the causal relationship between 211 intestinal flora and blood lipids. We screened 19 intestinal flora that might have an association with dyslipidemia in humans. Among them, Desulfovibrionaceae showed a stable and significant negative association with ApoB levels. These findings will provide a meaningful reference to discover dyslipidemia for intervention to address CVD in the clinic.

Availability of data and materials

Only publicly available GWAS summary data were used in this work. All raw data for this study are publicly available in the IEU Open GWAS Project repository (IEU OpenGWAS project (mercies. ac. UK)). Exposure dataset from MiBioGen consortium (https://mibiogen.gcc.rug.nl/). 211 GM taxa (including nine phyla, 16 classes, 20 orders, 35 families, and 131 genera). Outcome dataset can be found here: (https://mibiogen.gcc.rug.nl/UKBiobank.0

References

  1. Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. J Am Coll Cardiol. 2019;74(20):2529–32.

    Article  PubMed  Google Scholar 

  2. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254–743.

    Article  PubMed  Google Scholar 

  3. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000.

    Article  PubMed  Google Scholar 

  4. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115(4):450–8.

    Article  CAS  PubMed  Google Scholar 

  5. Erqou S, Kaptoge S, Perry PL, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–23.

    Article  CAS  PubMed  Google Scholar 

  6. Feingold KR. Introduction to lipids and lipoproteins[A]. In: Endotext Feingold KR, Anawalt B, Blackman MR et al. (eds). South Dartmouth (MA): MDText.com, Inc.Copyright © 2000-2024, MDText.com, Inc., 2000; 2024.

  7. Nayyer Uz Z, Dar MH, Adnan Y, et al. Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients. Pak J Med Sci. 2018;34(2):247–52.

    Google Scholar 

  8. Vrablík M, Ceska R, Horínek A. Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis. Physiol Res. 2001;50(4):337–43.

    PubMed  Google Scholar 

  9. Ostos MA, Conconi M, Vergnes L, et al. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21(6):1023–8.

    Article  CAS  PubMed  Google Scholar 

  10. Qu J, Ko CW, Tso P, et al. Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes. Cells. 2019;8(4):319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Alloubani A, Nimer R, Samara R. Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review. Curr Cardiol Rev. 2021;17(6):e051121189015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Brown MS, Goldstein JL. Heart attacks: gone with the century? Science. 1996;272(5262):629.

    Article  ADS  CAS  PubMed  Google Scholar 

  13. Grice EA, Segre JA. The human microbiome: our second genome. Annu Rev Genomics Hum Genet. 2012;13:151–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Koutnikova H, Genser B, Monteiro-Sepulveda M, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;9(3):e017995.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pérez-Matute P, Íñiguez M, de Toro M, et al. Autologous fecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice. Sci Rep. 2020;10(1):9388.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  16. Langgartner D, Vaihinger CA, Haffner-Luntzer M, et al. The Role of the Intestinal Microbiome in Chronic Psychosocial Stress-Induced Pathologies in Male Mice. Front Behav Neurosci. 2018;12:252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang H, Lu Y, Yan Y, et al. Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets. Front Cell Infect Microbiol. 2019;9:455.

    Article  CAS  PubMed  Google Scholar 

  18. Emoto T, Yamashita T, Sasaki N, et al. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb. 2016;23(8):908–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Wan X, Li T, Liu D, et al. Effect of Marine Microalga Chlorella pyrenoidosa Ethanol Extract on Lipid Metabolism and Gut Microbiota Composition in High-Fat Diet-Fed Rats. Mar Drugs. 2018;16(12):498.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Miyajima Y, Karashima S, Ogai K, et al. Impact of gut microbiome on dyslipidemia in japanese adults: Assessment of the Shika-machi super preventive health examination results for causal inference. Front Cell Infect Microbiol. 2022;12: 908997.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA. 2017;318(19):1925–6.

    Article  PubMed  Google Scholar 

  22. Smith GD, Ebrahim S. “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22.

    Article  PubMed  Google Scholar 

  23. Smith GD, Lawlor DA, Harbord R, et al. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 2007;4(12):e352.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Richardson TG, Sanderson E, Palmer TM, et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLoS Med. 2020;17(3):e1003062.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65.

    Article  ADS  PubMed  Google Scholar 

  28. Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–64.

    Article  PubMed  Google Scholar 

  29. Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362: k601.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880–906.

    Article  MathSciNet  PubMed  Google Scholar 

  34. Bowden J, Davey Smith G, Haycock PC, et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40(4):304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ni JJ, Xu Q, Yan SS, et al. Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study. Front Microbiol. 2021;12: 737197.

    Article  PubMed  Google Scholar 

  36. Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43(3):922–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–89.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kuziel GA, Rakoff-Nahoum S. The gut microbiome. Curr Biol. 2022;32(6):R257-r264.

    Article  CAS  PubMed  Google Scholar 

  41. Cowieson AJ. Comparative biology of germ-free and conventional poultry. Poult Sci. 2022;101(10).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Fan L, Ren J, Chen Y, et al. Effect of fecal microbiota transplantation on primary hypertension and the underlying mechanism of gut microbiome restoration: protocol of a randomized, blinded, placebo-controlled study. Trials. 2022;23(1):178.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Li Z, Lai J, Zhang P, et al. Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression. Mol Psychiatry. 2022;27(10):4123–35.

    Article  CAS  PubMed  Google Scholar 

  44. Goodrich JK, Davenport ER, Beaumont M, et al. Genetic Determinants of the Gut Microbiome in UK Twins. Cell Host Microbe. 2016;19(5):731–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210–5.

    Article  ADS  CAS  PubMed  Google Scholar 

  46. Liu B, Ye D, Yang H, et al. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn’s Disease. Front Immunol. 2022;13: 921546.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Hatcher C, Richenberg G, Waterson S, et al. Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer. Sci Rep. 2023;13(1):5968.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  48. Nava GM, Carbonero F, Croix JA, et al. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. Isme j. 2012;6(1):57–70.

    Article  CAS  PubMed  Google Scholar 

  49. Earley H, Lennon G, Balfe A, et al. A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis. PLoS One. 2015;10(10):e0135280.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Karlsson CL, Onnerfält J, Xu J, et al. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring). 2012;20(11):2257–61.

    Article  PubMed  Google Scholar 

  51. Andoh A, Nishida A, Takahashi K, et al. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population. J Clin Biochem Nutr. 2016;59(1):65–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, et al. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3:448.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Meng G, Zhao S, Xie L, et al. Protein S-sulfhydration by hydrogen sulfide in cardiovascular system. Br J Pharmacol. 2018;175(8):1146–56.

    Article  CAS  PubMed  Google Scholar 

  54. Carter RN, Morton NM. Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology. J Pathol. 2016;238(2):321–32.

    Article  CAS  PubMed  Google Scholar 

  55. Mani S, Li H, Untereiner A, et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation. 2013;127(25):2523–34.

    Article  CAS  PubMed  Google Scholar 

  56. Xu S, Liu Z, Liu P. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis. Int J Cardiol. 2014;172(2):313–7.

    Article  PubMed  Google Scholar 

  57. Hong Y, Li B, Zheng N, et al. Integrated Metagenomic and Metabolomic Analyses of the Effect of Astragalus Polysaccharides on Alleviating High-Fat Diet-Induced Metabolic Disorders. Front Pharmacol. 2020;11:833.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Hong Y, Sheng L, Zhong J, et al. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Gut Microbes. 2021;13(1):1–20.

    Article  CAS  PubMed  Google Scholar 

  59. Li L, He M, Xiao H, et al. Acetic Acid Influences BRL-3A Cell Lipid Metabolism via the AMPK Signalling Pathway. Cell Physiol Biochem. 2018;45(5):2021–30.

    Article  CAS  PubMed  Google Scholar 

  60. Li X, Chen H, Guan Y, et al. Acetic acid activates the AMP-activated protein kinase signaling pathway to regulate lipid metabolism in bovine hepatocytes. PLoS One. 2013;8(7):e67880.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  61. Duncan SH, Barcenilla A, Stewart CS, et al. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68(10):5186–90.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  62. Hiippala K, Jouhten H, Ronkainen A, et al. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients. 2018;10(8):988.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Li W, Zhu Y, Li Y, et al. The gut microbiota of hand, foot and mouth disease patients demonstrates down-regulated butyrate-producing bacteria and up-regulated inflammation-inducing bacteria. Acta Paediatr. 2019;108(6):1133–9.

    Article  CAS  PubMed  Google Scholar 

  64. Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107–13.

    Article  CAS  PubMed  Google Scholar 

  65. Hou Q, Zhao F, Liu W, et al. Probiotic-directed modulation of gut microbiota is basal microbiome dependent. Gut Microbes. 2020;12(1):1736974.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Gophna U, Konikoff T, Nielsen HB. Oscillospira and related bacteria - From metagenomic species to metabolic features. Environ Microbiol. 2017;19(3):835–41.

    Article  CAS  PubMed  Google Scholar 

  67. Arora T, Bäckhed F. The gut microbiota and metabolic disease: current understanding and future perspectives. J Intern Med. 2016;280(4):339–49.

    Article  CAS  PubMed  Google Scholar 

  68. Gao Z, Yin J, Zhang J, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Khan S, Jena G. Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: A comparative study with metformin. Chem Biol Interact. 2016;254:124–34.

    Article  CAS  PubMed  Google Scholar 

  70. Mollica MP, Mattace Raso G, Cavaliere G, et al. Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice. Diabetes. 2017;66(5):1405–18.

    Article  CAS  PubMed  Google Scholar 

  71. Bridgeman SC, Northrop W, Melton PE, et al. Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome. Pharmacol Res. 2020;160: 105174.

    Article  CAS  PubMed  Google Scholar 

  72. Yiew KH, Chatterjee TK, Hui DY, et al. Histone Deacetylases and Cardiometabolic Diseases. Arterioscler Thromb Vasc Biol. 2015;35(9):1914–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Hara T, Kimura I, Inoue D, et al. Free fatty acid receptors and their role in regulation of energy metabolism. Rev Physiol Biochem Pharmacol. 2013;164:77–116.

    Article  CAS  PubMed  Google Scholar 

  74. Ichimura A, Hasegawa S, Kasubuchi M, et al. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front Pharmacol. 2014;5:236.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Henneke L, Schlicht K, Andreani NA, et al. A dietary carbohydrate - gut Parasutterella - human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes. Gut Microbes. 2022;14(1):2057778.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Gu Y, Liu C, Zheng N, et al. Metabolic and Gut Microbial Characterization of Obesity-Prone Mice under a High-Fat Diet. J Proteome Res. 2019;18(4):1703–14.

    Article  CAS  PubMed  Google Scholar 

  77. Lee SH, You HS, Kang HG, et al. Association between Altered Blood Parameters and Gut Microbiota after Synbiotic Intake in Healthy, Elderly Korean Women. Nutrients. 2020;12(10):3112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Kim HJ, Jeong S, Oh YH, et al. Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants. Cardiovasc Diabetol. 2023;22(1):71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Zhu T, Wang Z, He J, et al. D-galactose protects the intestine from ionizing radiation-induced injury by altering the gut microbiome. J Radiat Res. 2022;63(6):805–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1):190–5.

    Article  PubMed  Google Scholar 

  81. López-Montoya P, Cerqueda-García D, Rodríguez-Flores M, et al. Association of Gut Microbiota with Atherogenic Dyslipidemia, and Its Impact on Serum Lipid Levels after Bariatric Surgery. Nutrients. 2022;14(17):3545.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Parks DH, Chuvochina M, Waite DW, et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat Biotechnol. 2018;36(10):996–1004.

    Article  CAS  PubMed  Google Scholar 

  83. Fu J, Bonder MJ, Cenit MC, et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids. Circ Res. 2015;117(9):817–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. He Y, Wu W, Wu S, et al. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome. 2018;6(1):172.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Rodrigues AC, Sobrino B, Genvigir FD, et al. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clin Chim Acta. 2013;417:8–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Natural Science Foundation of Shandong Province (ZR2022QH103).

Author information

Author notes

  1. Da Teng and Wenjuan Jia contributed equally to this work and share the first authorship.

Authors and Affiliations

  1. Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong, People’s Republic of China

    Da Teng, Wenjuan Jia, Wenlong Wang, Lei Gong, Haibin Dong, Lin Zhong & Jun Yang

  2. Qingdao University, Qingdao, Shandong, People’s Republic of China

    Da Teng, Wenjuan Jia & Wenlong Wang

  3. Binzhou Medical University, Yantai, Shandong, People’s Republic of China

    Bowen Xu

  4. Dazhou Central Hospital, Dazhou, Sichuan, People’s Republic of China

    Lanlan Liao

Authors
  1. Da Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenjuan Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenlong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lanlan Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bowen Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haibin Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lin Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Da Teng and Wenjuan Jia were responsible for the design, and data collection, Wenlong Wang and Lanlan Liao contributed to data analysis, Bowen Xu and Lei Gong contributed to the writing of the article; Haibin Dong funded the research; Lin Zhong and Jun Yang critically revised the final manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Lin Zhong or Jun Yang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication.

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teng, D., Jia, W., Wang, W. et al. Causality of the gut microbiome and atherosclerosis-related lipids: a bidirectional Mendelian Randomization study. BMC Cardiovasc Disord 24, 138 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s12872-024-03804-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12872-024-03804-3

Keywords

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us